Issue Cover

Digital

Innovations in pharmaceutical Digital Including Digital Labs, Blockchain, AI and Machine Learning

Articles

article-item
Revolutionising drug discovery with AI

For decades, bringing a drug from concept to patient access has been an expensive, convoluted and often uncertain journey. The traditional drug discovery process relies heavily on trial and error, biological hypotheses and rigid scientific processes. Various challenges significantly prolong the drug discovery process, ultimately slowing the pace of innovation and delivery of treatment for patients. Today, the integration of artificial intelligence into the drug discovery proc

17 June 2025Digital
article-item
Retrosynthesis: the reverse engineering of molecules

Retrosynthesis is the chemist’s toolkit for building complex molecules from simpler ones. Once rooted in intuition and experience, the process has been transformed by artificial intelligence and big data. This article explores how retrosynthesis works, why it matters and how it’s shaping the future of chemistry – from drug discovery to materials science

17 June 2025Digital
article-item
Real-time qualification: how digital systems are transforming compliance in life sciences

What’s the evolving impact of digitalisation on life sciences operations, and how can a systems-engineered approach help to create more resilient, flexible and future-ready compliant thermal processes?

17 June 2025Digital
article-item
AI in pharma and healthcare: redefining value through strategic innovation

From accelerating drug discovery to enabling earlier cancer diagnosis, how is artificial intelligence redefining value creation, transforming patient care and prompting a shift from reactive treatment to proactive intervention?

17 June 2025Digital
article-item
Transforming pharmaceutical manufacturing with cyber-physical trust

James Kugler at EMD Digital/Merck speaks to IPT about how counterfeit drugs, regulatory pressures and supply chain vulnerabilities demand a greater level of transparency in pharmaceutical manufacturing. Cyber-physical trust platforms, which provide an immutable link between physical products and their digital twins, will set a new standard and revolutionise the industry

17 March 2025Digital
article-item
How technology will shape pharma in 2025

How will advancements in technology affect the pharma sector, from both commercial and R&D points of view?

17 March 2025Digital
article-item
AI-powered pharma in 2025: faster drugs, safer patients, smarter healthcare

Digital tools, such as artificial intelligence, are improving pharma drug discovery

17 March 2025Digital
article-item
Cloud-based computing: driving next-generation drug development

Cloud-based tools like process analytical technology can be used to improve pharma manufacturing processes, speeding up quality assurance and time-to-market in a cost-effective manner

6 December 2024Digital
article-item
Harnessing AI in life sciences clinical R&D: use cases and benefits across eight key functions

The use of artificial intelligence is becoming increasingly common in life sciences R&D. In what areas can it be utilised in the most helpful manner?

6 December 2024Digital
article-item
The future of generative AI and automation in drug discovery

How is generative AI being utilised in drug discovery to improve processes and secure higher-quality drugs?

6 December 2024Digital
article-item
Transforming pharma companies for customer-centricity

The world is rapidly changing with numerous and frequent digital transformations. How can these be implemented and utilised effectively to ensure customer-centricity in the pharma sector?

6 December 2024Digital
article-item
Grounded in fact: making generative AI a success in drug discovery

AI, especially genAI, is becoming increasingly popular in the pharma and life sciences industries. How can companies use large language models – and more specifically, retrieval augmented generation architectures – to ensure AI-generated results are accurate?

22 September 2024Digital